Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (4): 455-460.doi: 10.16098/j.issn.0529-1356.2018.04.007

• Cancer Biology • Previous Articles     Next Articles

TRIM28siRNA enhancing the sensitivity of non-small cell lung cancer cell PAa to etoposide through activating E2F transcription factor 1

LIU Lei1 GAO Ya-xian1 WANG Jian-ping1 ZHAO Xue-rong1 XU Qian 2* HU Wang3 LIU Mei-qi4   

  1. 1.Department of Immunology; 2.Basic Medicine Laboratory; 3.Class 9 Grade 2014, Clinical Undergraduate; 4. Class 1 Grade 2014, Anesthesia Undergraduate, Institute of Basic Medicine, Chengde Medical College, Hebei Chengde067000, China
  • Received:2017-08-14 Revised:2017-11-22 Online:2018-08-06 Published:2018-08-06
  • Contact: XU Qian E-mail:xuqian@163.com

Abstract:

Objective  To investigate the effect of small interfering RNA (siRNA)-mediated silencing of TRIM28(tripartite motif containing 28)on the sensitivity of non-small cell lung cancer cell (NSCLC) PAa to etoposide and explore the possible mechanism. Methods  The expression of TRIM28 in PAa cell was silenced by RNA interference. MTT and colony formation assay were used to assess the inhibitory effect of TRIM28siRNA alone or in combination with etoposide on the growth and proliferation of PAa cells. The apoptosis of different groups was detected by flow cytometry(FCM ) and the expression of E2F transcription factor 1(E2F1) was evaluated by Western blotting. Results  A PAa cell line silenced with the TRIM28siRNA was established. TRIM28 in combination with etoposide significantly inhibited the proliferation and colony formation of PAa cells. TRIM28siRNA in combination with etoposide induced apoptosis and increased the expression of E2F1 at mRNA and protein levels. Conclusion  TRIM28siRNA in combination with etoposide has an obvious effect on the growth of NSCLC cells, suggesting a new clinical treatment strategy for NSCLC.

Key words: Non-small cell lung cancer, PAa cell, TRIM28, RNA interference, Etoposide, Western blotting, Human